Intracranial pressure monitoring associated with increased mortality in pediatric brain injuries.


Journal

Pediatric surgery international
ISSN: 1437-9813
Titre abrégé: Pediatr Surg Int
Pays: Germany
ID NLM: 8609169

Informations de publication

Date de publication:
Mar 2020
Historique:
accepted: 03 01 2020
pubmed: 16 1 2020
medline: 18 8 2020
entrez: 16 1 2020
Statut: ppublish

Résumé

Utilization of ICP monitors for pediatric patients is low and varies between centers. We hypothesized that in more severely injured patients (GCS 3-4), there would be a decreased mortality associated with invasive monitoring devices. The pediatric Trauma Quality Improvement Program (TQIP) was queried for patients aged ≤ 16 years meeting criteria for invasive monitors. Our primary outcome was mortality. Patients with ICP monitoring were compared to those without. A logistic regression was used to examine the risk of mortality. Of 3,808 patients, 685 (18.0%) underwent ICP monitoring. ICP monitors were associated with increased risk of mortality (OR 1.82, CI 1.36-2.44, p < 0.001). A secondary analysis including type of invasive ICP monitor and dividing GCS into 3 categories revealed both intraventricular drain (OR 1.89, CI 1.3-2.7, p = 0.001) and intraparenchymal pressure monitor (OR 1.86, CI 1.32-2.6, p < 0.001) to be independently associated with an increased likelihood of mortality regardless of GCS, while intraparenchymal oxygen monitoring was not (OR 0.47, CI 0.11-2.05, p = 0.316). The strongest effect was seen in those patients with a GCS of 5-6. ICP monitors are an independent risk factor for mortality, particularly with intraventricular drains and intraparenchymal monitors in patients with a GCS 5-6.

Sections du résumé

BACKGROUND BACKGROUND
Utilization of ICP monitors for pediatric patients is low and varies between centers. We hypothesized that in more severely injured patients (GCS 3-4), there would be a decreased mortality associated with invasive monitoring devices.
METHODS METHODS
The pediatric Trauma Quality Improvement Program (TQIP) was queried for patients aged ≤ 16 years meeting criteria for invasive monitors. Our primary outcome was mortality. Patients with ICP monitoring were compared to those without. A logistic regression was used to examine the risk of mortality.
RESULTS RESULTS
Of 3,808 patients, 685 (18.0%) underwent ICP monitoring. ICP monitors were associated with increased risk of mortality (OR 1.82, CI 1.36-2.44, p < 0.001). A secondary analysis including type of invasive ICP monitor and dividing GCS into 3 categories revealed both intraventricular drain (OR 1.89, CI 1.3-2.7, p = 0.001) and intraparenchymal pressure monitor (OR 1.86, CI 1.32-2.6, p < 0.001) to be independently associated with an increased likelihood of mortality regardless of GCS, while intraparenchymal oxygen monitoring was not (OR 0.47, CI 0.11-2.05, p = 0.316). The strongest effect was seen in those patients with a GCS of 5-6.
CONCLUSION CONCLUSIONS
ICP monitors are an independent risk factor for mortality, particularly with intraventricular drains and intraparenchymal monitors in patients with a GCS 5-6.

Identifiants

pubmed: 31938835
doi: 10.1007/s00383-020-04618-y
pii: 10.1007/s00383-020-04618-y
pmc: PMC7223517
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

391-398

Références

Neurol India. 2016 Sep-Oct;64(5):958-61
pubmed: 27625237
J Neurotrauma. 2016 May 1;33(9):853-8
pubmed: 26414629
Neurosurgery. 2013 Nov;73(5):746-52; discussion 752; quiz 752
pubmed: 23863766
Acta Neurochir Suppl. 2018;126:39-45
pubmed: 29492529
Pediatr Neurosurg. 2018;53(6):379-386
pubmed: 30404096
Childs Nerv Syst. 2009 Oct;25(10):1325-33
pubmed: 19214532
Pediatr Crit Care Med. 2013 Mar;14(3):239-47
pubmed: 23392360
JAMA Pediatr. 2017 Oct 1;171(10):965-971
pubmed: 28846763
Intensive Care Med. 2013 Jan;39(1):129-36
pubmed: 23179331
N Engl J Med. 2012 Dec 27;367(26):2471-81
pubmed: 23234472
J Neurosurg. 2018 Mar;128(3):828-833
pubmed: 28548592
J Neurotrauma. 2017 Jul 15;34(14):2220-2229
pubmed: 28052716
BMC Anesthesiol. 2016 Jul 11;16(1):35
pubmed: 27401211
Pediatr Crit Care Med. 2016 Nov;17(11):1064-1072
pubmed: 27632060
Injury. 2017 Sep;48(9):1944-1950
pubmed: 28495204
Intensive Care Med. 1983;9(1):13-6
pubmed: 6833623
PLoS One. 2016 Mar 15;11(3):e0148817
pubmed: 26978532
MMWR Surveill Summ. 2017 Mar 17;66(9):1-16
pubmed: 28301451
J Trauma. 2011 Nov;71(5):1172-8
pubmed: 22071922
World Neurosurg. 2015 May;83(5):794-800
pubmed: 25541084
Pediatr Crit Care Med. 2012 Jan;13 Suppl 1:S1-82
pubmed: 22217782
J Trauma. 2008 Feb;64(2):335-40
pubmed: 18301195
Am J Surg. 2015 Dec;210(6):1082-6; discussion 1086-7
pubmed: 26482513
J Neurosurg Pediatr. 2015 Nov;16(5):523-532
pubmed: 26273741
J Trauma Acute Care Surg. 2015 Mar;78(3):492-501; discussion 501-2
pubmed: 25710418
J Neurosurg. 2013 Nov;119(5):1248-54
pubmed: 23971954
JAMA Surg. 2014 Jun;149(6):544-8
pubmed: 24789426
Am Surg. 2008 Nov;74(11):1088-93
pubmed: 19062667
Intensive Care Med. 2006 Oct;32(10):1606-12
pubmed: 16874495
J Neurosurg. 2012 Oct;117(4):729-34
pubmed: 22900846
Acta Neurochir Suppl. 2016;122:187-91
pubmed: 27165904
Arch Pediatr Adolesc Med. 2012 Jul 1;166(7):641-7
pubmed: 22751878
J Surg Res. 2015 Apr;194(2):565-570
pubmed: 25553841
Neurosurgery. 2017 Jan 01;80(1):6-15
pubmed: 27654000
J Neurotrauma. 2007;24 Suppl 1:S1-106
pubmed: 17511534
Childs Nerv Syst. 2015 Nov;31(11):2011-4
pubmed: 26216060

Auteurs

Patrick T Delaplain (PT)

Department of Surgery, University of California, Irvine Medical Center, 333 City Blvd West, Suite 1600, Orange, CA, 92868, USA. pdelapla@uci.edu.

Areg Grigorian (A)

Department of Surgery, University of California, Irvine Medical Center, 333 City Blvd West, Suite 1600, Orange, CA, 92868, USA.

Michael Lekawa (M)

Department of Surgery, University of California, Irvine Medical Center, 333 City Blvd West, Suite 1600, Orange, CA, 92868, USA.

Michael Mallicote (M)

Department of Pediatric Surgery, Children's Hospital Los Angeles, 4650 Sunset Blvd., Mailstop #100, Los Angeles, CA, 90027, USA.

Victor Joe (V)

Department of Surgery, University of California, Irvine Medical Center, 333 City Blvd West, Suite 1600, Orange, CA, 92868, USA.

Sebastian D Schubl (SD)

Department of Surgery, University of California, Irvine Medical Center, 333 City Blvd West, Suite 1600, Orange, CA, 92868, USA.

Catherine M Kuza (CM)

Department of Anesthesiology, University of Southern California, 1450 San Pablo Street Suite 360, Los Angeles, CA, 90033, USA.

Matthew Dolich (M)

Department of Surgery, University of California, Irvine Medical Center, 333 City Blvd West, Suite 1600, Orange, CA, 92868, USA.

Jeffry Nahmias (J)

Department of Surgery, University of California, Irvine Medical Center, 333 City Blvd West, Suite 1600, Orange, CA, 92868, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH